IP Verse

Abkevich competitive analysis

Loading summary...

Latest patents of Abkevich opposed by its competitors

Explore Abkevich's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Oct 30, 2025
Patent NumberGrant DateTitleTotal Oppositions
EP2794907
Nov 23, 2022Methods And Materials For Assessing Loss Of Heterozygosity1
EP2981624
Dec 18, 2019Methods And Materials For Assessing Homologous Recombination Deficiency1

Latest publications and patents of Abkevich New

Explore the latest publications and patents granted to Abkevich, showcasing their recent innovations and technological advancements.

Last updated on: Oct 24, 2025
Publication NumberPublication DateTitleLegal Status

Get instant update for new patents of Abkevich

EP2794907
Nov 23, 2022Methods And Materials For Assessing Loss Of HeterozygosityPatent Maintained As Amended
EP2981624
Dec 18, 2019Methods And Materials For Assessing Homologous Recombination DeficiencyOpposition Rejected

Latest PTAB cases involving Abkevich

Discover the latest PTAB cases involving Abkevich, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Abkevich with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Oct 30, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
ABKEVICH - 2 - -
NEO NEW ONCOLOGY1 - - -
SIEMENS HEALTHCARE17 - - -